Glutathione S-transferase (GST) gene variants and risk of benign prostatic hyperplasia: A report in a North Indian population

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 1067-1072

  Konwar, Rituraj ^a   Manchanda, Parmeet Kaur ^b   Chaudhary, Preeti ^a   Lakshma Nayak, V ^a   Singh, Vishwajeet ^c   Bid, Hemant Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b OHIO STATE UNIVERSITY   (United States)

^c KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

BPH; Glutathione S transferase; India; Polymorphism; Symptomatic benign prostatic hyperplasia

Indexed keywords

EID: 78650706555     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Arand M, Mühlbauer R, Hengstler J, et al (1996). A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem, 236, 184-6.
2. Bostwick DG, Ie M, Shanks J (2007). Glutathione S-transferase: differential expression of α, μ, and π isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. Hum Pathol, 38, 1394-401.
3. Cookson MS, Reuter VE, Linkov I, et al (1997). Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J Urol, 7, 673-6.
4. De Marzo AM, Marchi VL, Epstein JI, et al (1999). Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol, 155, 1985-92.
5. De Marzo AM, Nelson WG, Meeker AK, et al (1998). Stem cell features of benign and malignant prostate epithelial cells. J Urol, 160, 2381-92.
6. Di Ilio C, Aceto A, Bucciarelli T, et al (1990). Glutathione transferase isoenzymes from human prostate. Biochem J, 271, 481-5.
7. Dragin N, Smani M, Arnaud-Dabernat S, et al (2006). Acute oxidative stress is associated with cell proliferation in the mouse liver. FEBS Lett, 580, 3845-52.
8. Egan KM, Cai Q, Shu XO, et al (2004). Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: Results from the Shanghai breast cancer study and meta-analysis. Cancer Epidemiol Biomarkers Prev, 13, 197-204.
9. Engel LS, Taioli E, Pfeiffer R, et al (2002). Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol, 156, 95-109.
10. Gauderman WJ (2002). Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol, 155, 478-84.
11. Habdous M, Siest G, Herbeth B, et al (2004). Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies. Ann Biol Clin (Paris), 62, 15-24.
12. Harries LW, Stubbins MJ, Forman D, et al (1997). Identification of genetic polymorphisms at the glutathione S transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis, 18, 641-4.
13. Henrique R, Jeronimo C (2004). Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Euro Urol, 46, 660-9.
14. Kramer G, Mitteregger D, Marberger M (2007). Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Euro Urol, 51, 1202-16.
15. Konwar R, Chattopadhyay N, Bid HK (2008). Genetic polymorphism and pathogenesis of benign prostatic hyperplasia. BJU Int, 102, 536-44.
16. Lai R, Crevier L, Thabane L (2005). Genetic polymorphisms of glutathione s-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 14, 784-90.
17. Madersbacher S, Alivizatos G, Nordling J, et al (2004). EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH Guidelines). Euro Urol, 46, 547-54.
18. Mishra DK, Kumar A, Srivastava DS (2004). Allelic variation of GSTT1, GSTM1 and GSTP1 genes in north indian population. Asian Pac J Cancer Prev, 5, 362-5.
19. Ntais C, Polycarpou A, Ioannidis JP (2005). Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 14, 176-181.
20. Nebert DW, Vasiliou V (2004). Analysis of the glutathione S-transferase (GST) gene family. Hum Genomics, 1, 460-4.
21. Palapattu GS, Sutcliffe S, Bastian PJ, et al (2005). Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis, 26, 1170-81.
22. Pandey SN, Jain M, Nigam P (2006). Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India. Biomarkers, 11, 250-61.
23. Sciarra A, Di Silverio F, Salciccia S et al, (2007). Inflammation and chronic prostatic diseases: evidence for a link? Euro Urol, 52, 964-72.
24. Srivastava DSL, Mittal RD (2005). Free radical injury and antioxidant status in patients with benign prostate hyperplasia and prostate cancer. Indian J Clin Biochem, 20, 162-5.
25. Vineis P (2002). The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicol, 181-182, 457-62.
26. Mittal RD, Kesarwani P, Singh R, et al (2009). GSTM1, GSTM3 and GSTT1 gene variants and risk of benign prostate hyperplasia in North India. Dis Markers, 26, 85-91.
27. Willett W (1989). The search for the causes of breast and colon cancer. Nature, 338, 389-94.